{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:25:03Z","timestamp":1786951503168,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Discipline Construction and Development Fund of Liangjiang New Area People's Hospital, Chongqing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09821-y","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:48:47Z","timestamp":1786949327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of multiple sclerosis burden in China and India from 1990 to 2021 based on the Global Burden of Disease Study 2021"],"prefix":"10.1007","volume":"74","author":[{"given":"Zhuo-lei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-you","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"6","key":"9821_CR1","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1039\/C7SC03992A","volume":"9","author":"KWC Poon","year":"2018","unstructured":"Poon KWC, Brideau C, Klaver R, Schenk GJ, Geurts JJ, Stys PK. Lipid biochemical changes detected in normal appearing white matter of chronic multiple sclerosis by spectral coherent Raman imaging. Chem Sci. 2018;9(6):1586\u201395.","journal-title":"Chem Sci"},{"issue":"1","key":"9821_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nbd.2010.12.003","volume":"45","author":"R Dutta","year":"2012","unstructured":"Dutta R, Trapp BD. Gene expression profiling in multiple sclerosis brain. Neurobiol Dis. 2012;45(1):108\u201314.","journal-title":"Neurobiol Dis"},{"issue":"32","key":"9821_CR3","doi-asserted-by":"publisher","first-page":"8040","DOI":"10.1523\/JNEUROSCI.1947-08.2008","volume":"28","author":"C Costa","year":"2008","unstructured":"Costa C, Belcastro V, Tozzi A, Di Filippo M, Tantucci M, Siliquini S, Autuori A, Picconi B, Spillantini MG, Fedele E, et al. Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J Neurosci. 2008;28(32):8040\u201352.","journal-title":"J Neurosci"},{"issue":"2","key":"9821_CR4","first-page":"125","volume":"54","author":"A Kalinowska","year":"2020","unstructured":"Kalinowska A, Kulakowska A, Adamczyk-Sowa M, Czajkowski K, Kurowska K, Pietrzak B, Radziszewski P, Rejdak K, Bartosik-Psujek H. Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society. Neurol Neurochir Pol. 2020;54(2):125\u201337.","journal-title":"Neurol Neurochir Pol"},{"issue":"Pt 5","key":"9821_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009;132(Pt 5):1161\u201374.","journal-title":"Brain"},{"issue":"1","key":"9821_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00312546","volume":"215","author":"JF Kurtzke","year":"1977","unstructured":"Kurtzke JF. Geography in multiple sclerosis. J Neurol. 1977;215(1):1\u201326.","journal-title":"J Neurol"},{"key":"9821_CR7","doi-asserted-by":"publisher","first-page":"102885","DOI":"10.1016\/j.msard.2021.102885","volume":"51","author":"S Bonomi","year":"2021","unstructured":"Bonomi S, Jin S, Culpepper WJ, Wallin MT. MS and Disability Progression in Latin America, Africa, Asia and the Middle East: A Systematic Review. Mult Scler Relat Disord. 2021;51:102885.","journal-title":"Mult Scler Relat Disord"},{"key":"9821_CR8","doi-asserted-by":"publisher","first-page":"106667","DOI":"10.1016\/j.msard.2025.106667","volume":"103","author":"S Mrabet","year":"2025","unstructured":"Mrabet S, Garcia EC, Giovannoni G. Prediction of long-term outcome in Multiple Sclerosis: A systematic review. Mult Scler Relat Disord. 2025;103:106667.","journal-title":"Mult Scler Relat Disord"},{"key":"9821_CR9","doi-asserted-by":"publisher","first-page":"103621","DOI":"10.1016\/j.autrev.2024.103621","volume":"23","author":"C Hao","year":"2024","unstructured":"Hao C, Ting L, Feng G, Jing X, Ming H, Yang L, Jie Z, Yin J. Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021. Autoimmun Rev. 2024;23:103621.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"9821_CR10","doi-asserted-by":"publisher","first-page":"e066335","DOI":"10.1136\/bmjopen-2022-066335","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, Zhou N, Duan S, Zhong H, Jiang R, Yuan N. Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open. 2022;12(12):e066335.","journal-title":"BMJ Open"},{"key":"9821_CR11","doi-asserted-by":"publisher","first-page":"1616245","DOI":"10.3389\/fneur.2025.1616245","volume":"16","author":"LY Wang","year":"2025","unstructured":"Wang LY, Wang WF, Hui SY, Yang L, Liu YX, Li HJ. Emerging epidemiological trends of multiple sclerosis among adults aged 20\u201354 years, 1990\u20132021, with projections to 2035: a systematic analysis for the global burden of disease study 2021. Front Neurol. 2025;16:1616245.","journal-title":"Front Neurol"},{"key":"9821_CR12","doi-asserted-by":"publisher","first-page":"1073278","DOI":"10.3389\/fpubh.2023.1073278","volume":"11","author":"Z Qian","year":"2023","unstructured":"Qian Z, Li Y, Guan Z, et al. Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019. Front Public Health. 2023;11:1073278.","journal-title":"Front Public Health"},{"key":"9821_CR13","doi-asserted-by":"publisher","first-page":"103119","DOI":"10.1016\/j.msard.2021.103119","volume":"54","author":"A Forouhari","year":"2021","unstructured":"Forouhari A, Taheri G, Salari M, Moosazadeh M, Etemadifar M. Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis. Mult Scler Relat Disord. 2021;54:103119.","journal-title":"Mult Scler Relat Disord"},{"issue":"10440","key":"9821_CR14","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10469","key":"9821_CR15","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/S0140-6736(24)01446-6","volume":"404","author":"GBD 2021 US Burden of Disease Collaborators","year":"2024","unstructured":"GBD 2021 US Burden of Disease Collaborators. The burden of diseases, injuries, and risk factors by state in the USA, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;404(10469):2314\u201340.","journal-title":"Lancet"},{"issue":"10440","key":"9821_CR16","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"3","key":"9821_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"key":"9821_CR18","volume-title":"Standardization and decomposition of rates: a user\u2019s manual","author":"P Das Gupta","year":"1993","unstructured":"Das Gupta P. Standardization and decomposition of rates: a user\u2019s manual. Washington, DC: US Bureau of the Census; 1993."},{"issue":"3","key":"9821_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","volume":"59","author":"A Riebler","year":"2017","unstructured":"Riebler A, Held L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J. 2017;59(3):531\u201349.","journal-title":"Biom J"},{"issue":"8","key":"9821_CR20","doi-asserted-by":"publisher","first-page":"e1129","DOI":"10.1016\/S2214-109X(21)00164-9","volume":"9","author":"India State-Level Disease Burden Initiative Neurological Disorders Collaborators","year":"2021","unstructured":"India State-Level Disease Burden Initiative Neurological Disorders Collaborators. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990\u20132019. Lancet Glob Health. 2021;9(8):e1129\u201344.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"9821_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/imm.13389","volume":"164","author":"J Correale","year":"2021","unstructured":"Correale J, Marrodan M, Carnero Contentti E. Interleukin-35 is a critical regulator of immunity during helminth infections associated with multiple sclerosis. Immunology. 2021;164(3):569\u201386.","journal-title":"Immunology"},{"issue":"6","key":"9821_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2022-329074","volume":"93","author":"JN Brenton","year":"2022","unstructured":"Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, Coleman R, Conaway M, Goldman MD. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637\u201344.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9821_CR23","doi-asserted-by":"publisher","first-page":"1004147","DOI":"10.37349\/ent.2026.1004147","volume":"6","author":"L Pinheiro","year":"2026","unstructured":"Pinheiro L, Valado A. HLA polymorphisms with high expression in multiple sclerosis: systematic review. Explor Neuroprot Ther. 2026;6:1004147.","journal-title":"Explor Neuroprot Ther"},{"key":"9821_CR24","doi-asserted-by":"publisher","first-page":"104685","DOI":"10.1016\/j.meegid.2020.104685","volume":"89","author":"N Rangasamy","year":"2021","unstructured":"Rangasamy N, Chinniah R, Ravi PM, et al. HLA-DRB1* and DQB1* allele and haplotype diversity in eight tribal populations: Global affinities and genetic basis of diseases in South India. Infect Genet Evol. 2021;89:104685.","journal-title":"Infect Genet Evol"},{"issue":"12","key":"9821_CR25","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1177\/1352458513482375","volume":"19","author":"L Pandit","year":"2013","unstructured":"Pandit L, Ramagopalan SV, Malli C, D\u2019Cunha A, Kunder R, Shetty R. Association of vitamin D and multiple sclerosis in India. Mult Scler. 2013;19(12):1592\u20136.","journal-title":"Mult Scler"},{"key":"9821_CR26","first-page":"47","volume":"10","author":"SV Khadilkar","year":"2005","unstructured":"Khadilkar SV, Sahni AO, Agarwal S. A case control study of environmental risk factors in Indians with multiple sclerosis. Neurol Asia. 2005;10:47\u201352.","journal-title":"Neurol Asia"},{"issue":"1","key":"9821_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/ene.15066","volume":"29","author":"S Simpson-Yap","year":"2022","unstructured":"Simpson-Yap S, Nag N, Probst Y, Jelinek G, Neate S. Higher-quality diet and non-consumption of meat are associated with less self-determined disability progression in people with multiple sclerosis: A longitudinal cohort study. Eur J Neurol. 2022;29(1):225\u201336.","journal-title":"Eur J Neurol"},{"issue":"1","key":"9821_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13167-019-00191-0","volume":"11","author":"Y Beckmann","year":"2020","unstructured":"Beckmann Y, T\u00fcre S, Duman SU. Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients. EPMA J. 2020;11(1):65\u201372.","journal-title":"Epma j"},{"key":"9821_CR29","doi-asserted-by":"publisher","first-page":"677041","DOI":"10.3389\/fimmu.2021.677041","volume":"12","author":"EB Cho","year":"2021","unstructured":"Cho EB, Shin JH, Kwon S, Kim J, Seok JM, Kim BJ, Min JH. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D(3)In Vitro in Patients With Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder. Front Immunol. 2021;12:677041.","journal-title":"Front Immunol"},{"issue":"10","key":"9821_CR30","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019;92(10):e1029\u201340.","journal-title":"Neurology"},{"issue":"11","key":"9821_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","volume":"83","author":"P Browne","year":"2014","unstructured":"Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014;83(11):1022\u20134.","journal-title":"Neurology"},{"issue":"12","key":"9821_CR32","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1177\/1352458514521503","volume":"20","author":"L Pandit","year":"2014","unstructured":"Pandit L, Kundapur R. Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India. Mult Scler. 2014;20(12):1651\u20133.","journal-title":"Mult Scler"},{"issue":"3","key":"9821_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/WCO.0000000000001359","volume":"38","author":"D Jia","year":"2025","unstructured":"Jia D, Shi FD, Jiang W. Multiple sclerosis in China: the current state of diagnosis and management. Curr Opin Neurol. 2025;38(3):236\u201342.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"9821_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380.","journal-title":"Lancet Neurol"},{"issue":"3","key":"9821_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"GBD 2016 Multiple Sclerosis Collaborators","year":"2019","unstructured":"GBD 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(3):269\u201385.","journal-title":"Lancet Neurol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09821-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09821-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09821-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:48:48Z","timestamp":1786949328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09821-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9821"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09821-y","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For the GBD is publicly available and no identifiable information was included in the analyses, the ethical approval and informed consent were not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"87"}}